Supplementary Figure S4 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer

作者：Catherine Lee, Ziyue Karen Jiang, Simon Planken, Lisa K. Manzuk, Roberto Ortiz, Michael Hall, Kavon Noorbehesht, Sripad Ram, Timothy Affolter, Gabriel E. Troche, Nathan T. Ihle, Theodore Johnson, Youngwook Ahn, Manfred Kraus, Anand Giddabasappa · 年份：2025 · DOI：10.1158/1535-7163.30733962 · 研究领域：Protein Kinase Regulation and GTPase Signaling、Receptor Mechanisms and Signaling、HER2/EGFR in Cancer Research

<p>Baseline differences in tumor progression and histopathology of G12D versus G12C KP GEM models</p>